What is Xogene?
Xogene operates at the intersection of clinical trial transparency and advanced technology, providing a comprehensive suite of services designed to optimize compliance and disclosure workflows. By leveraging AI-driven platforms, the company assists over 45 biopharma clients in navigating the intricate requirements of global clinical data management. Their service model integrates specialized advisory, medical writing, and data protection protocols, effectively transforming raw clinical trial data into actionable, accessible information. This holistic approach not only enhances operational efficiency for trial sponsors but also fosters improved engagement with patients and caregivers, establishing Xogene as a critical infrastructure partner in the modern pharmaceutical ecosystem.
How much funding has Xogene raised?
Xogene has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Xogene
PPP
Public-Private Partnership
What's next for Xogene?
Following this late-stage funding, Xogene is poised to scale its technological infrastructure and expand its footprint in the global biopharma market. The strategic allocation of these resources will likely focus on enhancing the predictive capabilities of their AI-driven platforms and deepening their advisory services to meet evolving international regulatory standards. As the industry faces increasing pressure for transparency and data integrity, Xogene's ability to provide scalable, compliant solutions positions it to capture further market share. The company's growth trajectory suggests a continued emphasis on product innovation and the potential for strategic partnerships that could further solidify its role as a leader in clinical trial transparency solutions.
See full Xogene company page
